Avalo Therapeutics Inc.

4.78
-0.10 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
4.67
-2.30%
After-hours: Apr 25, 2025, 04:21 PM EDT

Avalo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-35.13M -31.54M -41.66M -84.38M -63.5M -16.07M -40.05M 11.87M -16.47M
169K 158K 166K 1.66M 1.84M 3.88M 4.55M 425.48K 26.86K
5.85M 3.48M 7.55M 8.17M 6.79M 2.53M 2.43M 1.16M 1.69M
-4.54M -8.61M 4.18M 961K -3.88M -5.24M 9.18M -113K -245.03K
-15.35M 6.46M 2.39M 794K 18.57M -7.47M 21.22M 366.23K 162.27K
114K 14K 28K 22K 195.59K 16.74K -16.75K -832.63K -72.63K
-4.71M -9.24M 4.77M 2.84M -4.44M -2.03M 8.73M -466.75K 87.07K
-49.06M -30.68M -26.75M -70.89M -40.54M -19.13M -3.13M 12.52M -14.57M
n/a -158K -95K -113K -62.66K -262.01K -564.41K -23.32K -34.88K
n/a n/a n/a n/a 11.19M 3.96M 1.43M -18.89M n/a
n/a n/a n/a n/a -11,194.9B n/a n/a n/a n/a
n/a n/a n/a n/a 12,836.7B n/a n/a n/a n/a
356K 25K n/a n/a -1,641.8B -4.14M -1K n/a n/a
356K -133K -95K -113K 11.13M -443K 865.46K -18.91M -34.88K
n/a -21.24M n/a 32.9M n/a -256.14K n/a -2.37M -3.31M
68K n/a -14.81M n/a n/a -33.96K n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
60.22M 67K -14.7M 1.93M -93.87K 131.07K 6.55M -232.38K -114.94K
175.85M 25.04M -14.7M 106.76M 44.78M 12.56M 10.4M 3.74M -1.43M
127.15M -5.77M -41.55M 35.76M 15.38M -7.02M 8.14M -2.66M -16.03M
-49.06M -30.84M -26.85M -71M -40.6M -19.4M -3.69M 12.5M -14.61M